Clinical trial
Retinoic Acid Effect on Cell Surface Molecules in Vivo
NCT03753867 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retinoic Acid Effect on Cell Surface Molecules in Vivo
- Lead sponsor
- Ottawa Hospital Research Institute
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- January 7, 2019
- Completion date
- May 8, 2019
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.